Neil Woodford’s trust backs £31.5m round in UK cancer genomics company Inivata

The Woodford Patient Capital Trust, a vehicle of renowned British fund manager Neil Woodford, came in as a new investor in a £31.5m Series A round in UK-based clinical cancer genomics company Inivata.